Pos Malaysia Bhd (Pos Malaysia) appoints Roshidah Abdullah as non-independent and non-executive director effective Jan 1, 2024.
In a Bursa fiiling today, the group said Roshidah, 56, has more than 25 years experience financial management, corporate strategy development, governance and risk management in various organisations across diverse industries.
Among the industry that she has served in were upstream oil and gas, pharmaceutical manufacturing and distribution, construction and engineering, with operations in Malaysia and abroad, it added.
“Roshidah started her career as an auditor at Deloitte Touche Tohmatsu LLC (Kassim Chan & Co) in 1989. She left the firm in December 1992 to join Time Engineering Bhd as a group accountant.
“In January 1995, she moved to Remedi Pharmaceuticals (M) Sdn Bhd (Remedi) to head the Finance Department. She was involved in the merger and acquisition of Remedi, Raza Manufacturing Berhad and Strand Pharmaceuticals Sdn Bhd by Pharmaniaga Bhd (Pharmaniaga) in 1998 and the subsequent public listing of Pharmaniaga on Bursa Securities in 1999.
“(While in Pharmaniaga), she was promoted as the Finance general manager in January 2000 and later in April 2003, as Pharmaniaga chief financial officer. She was appointed as Pharmaniaga chief operating officer from 2006 to March 2008.
Roshidah then spent the next two years until early 2010 as the UEM Group Bhd finance director and UEM Builders Bhd before she returned to Pharmaniaga to assist the company to amongst others, finalise its negotiation for renewal of the concession agreement and prepare for the change in controlling shareholders.
“After leaving Pharmaniaga in March 2011, she had a short stint as a business consultant and she was Sumatec Resources Bhd chief financial officer from April 2013 to October 2016.
Roshidah was also appointed as a Audit Committee chairman and as a member to the Board Tender Committee (BTC) on the same day of her directorial appointment.
